Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest (Kane Biotech Inc)

(Source: Kane Biotech Inc) Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest WINNIPEG, Manitoba --(Marketwired - December 23, 2014) - Kane Biotech Inc. (TSX-V:KNE) (the "Corporation") announced that on December 19, 2014, it issued 251,392 common shares of the Corporation ("Common Shares") in payment of $12,569.62 in interest owing on the Corporation's $500,000 2 year 10% convertible redeemable unsecured note (the "Note") as at March 18, 2014. Pursuant to the terms of the Note, the Corporation has the option to issue Common Shares in lieu of cash in payment of interest on the Note at a deemed price per share equal to the market price of the Common Shares on...